To determine whether PLK1 is a potential molecular target in the treatment of men who develop castration resistant prostate cancer.
|Effective start/end date||6/1/15 → 11/30/16|
- U.S. Army Medical Research and Materiel Command (W81XWH-15-1-0105)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.